Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer
- PMID: 20106588
- DOI: 10.1016/j.eururo.2009.12.034
Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer
Abstract
Background: Positive lymph node (LN) status is considered a systemic disease state. In prostate cancer, LN-positive diagnosis during pelvic LN dissection (PLND) potentially leads to the abandonment of radical prostatectomy (RP).
Objective: To compare the overall survival (OS) and relative survival (RS; as an estimate for cancer-specific survival) in LN-positive patients with or without RP.
Design, setting, and participants: Between 1988 and 2007, a total of 35 629 men with prostate cancer were identified at the Munich Cancer Registry; of those, 1413 patients had positive LNs.
Intervention: Of these 1413 LN-positive patients, prostatectomy was abandoned in 456 LN-positive patients, whereas 957 underwent RP despite the LN-positive finding.
Measurements: Crucial analyses are based on 938 LN-positive patients (688 with RP and 250 without RP) with complete data regarding age, grade, and prostate-specific antigen (PSA). OS (Kaplan-Meier estimates) and RS are presented, and Cox regression analysis was used to show the influence of predictors such as clinical stage, age at surgery, number of positive LNs, PSA level, grade, and extent of surgery.
Results: Median follow-up was 5.6 yr. OS of patients at 5 yr and 10 yr was 84% and 64%, respectively, with RP and was 60% and 28%, respectively, with aborted RP. The RS of patients at 5 yr and 10 yr was 95% and 86%, respectively, with RP and was 70% and 40%, respectively, with abandoned surgery. There was an imbalance, however, in the number of positive LNs: 17.2% with RP had four or more positive nodes versus 28% in the patient group without RP. In the multivariate model, RP was a strong independent predictor of survival (hazard ratio: 2.04 [95% confidence interval, 1.59-2.63; p<0.0001]).
Conclusion: LN-positive patients with complete RP had improved survival compared to patients with abandoned RP. These results suggest that RP may have a survival benefit and the abandonment of RP in node-positive cases may not be justified.
Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Can radical prostatectomy benefit patients despite the presence of regional metastases?Eur Urol. 2010 May;57(5):762-3; author reply 763-5. doi: 10.1016/j.eururo.2010.01.017. Epub 2010 Jan 22. Eur Urol. 2010. PMID: 20096990 No abstract available.
-
Re: Jutta Engel, Patrick J. Bastian, Helmut Baur, et al. Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol 2010;57:754-61.Eur Urol. 2010 Oct;58(4):e43; author reply e44. doi: 10.1016/j.eururo.2010.06.030. Epub 2010 Jul 12. Eur Urol. 2010. PMID: 20633982 No abstract available.
-
Re: Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer.Eur Urol. 2010 May;57(5):915-6. doi: 10.1016/j.eururo.2010.02.011. Eur Urol. 2010. PMID: 20945545 No abstract available.
Similar articles
-
Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?J Urol. 2003 Mar;169(3):849-54. doi: 10.1097/01.ju.0000049032.38743.c7. J Urol. 2003. PMID: 12576797
-
The impact of the extent of lymph-node dissection on biochemical relapse after radical prostatectomy in node-negative patients.Anticancer Res. 2010 Jun;30(6):2297-302. Anticancer Res. 2010. PMID: 20651383
-
The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.Can J Urol. 2009 Oct;16(5):4842-6. Can J Urol. 2009. PMID: 19796462
-
No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.Urology. 2004 Mar;63(3):528-31. doi: 10.1016/j.urology.2003.09.064. Urology. 2004. PMID: 15028451 Review.
-
Lymph node positive prostate cancer: long-term survival data after radical prostatectomy.J Urol. 2004 Mar;171(3):1128-31. doi: 10.1097/01.ju.0000113202.37783.1f. J Urol. 2004. PMID: 14767285 Review.
Cited by
-
[Resection of metastases from prostate cancer].Urologe A. 2012 Mar;51(3):363-7. doi: 10.1007/s00120-012-2827-4. Urologe A. 2012. PMID: 22358376 Review. German.
-
Primary melanoma of the prostate: case report and review of the literature.BMC Urol. 2015 Jul 14;15:68. doi: 10.1186/s12894-015-0052-3. BMC Urol. 2015. PMID: 26169921 Free PMC article. Review.
-
Emerging role of cytoreductive prostatectomy in patients with metastatic disease.Transl Androl Urol. 2018 Sep;7(Suppl 4):S505-S513. doi: 10.21037/tau.2018.06.06. Transl Androl Urol. 2018. PMID: 30363448 Free PMC article. Review.
-
Sense and nonsense of an extended pelvic lymph node dissection in prostate cancer.Adv Urol. 2012;2012:983058. doi: 10.1155/2012/983058. Epub 2011 Oct 9. Adv Urol. 2012. PMID: 22007203 Free PMC article.
-
Predictive value of positive surgical margins after radical prostatectomy for lymph node metastasis in locally advanced prostate carcinoma.Adv Urol. 2012;2012:618574. doi: 10.1155/2012/618574. Epub 2011 Oct 3. Adv Urol. 2012. PMID: 21977027 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous